These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7535437)

  • 1. The clinical use of elutriation and positive stem cell selection columns to engineer the lymphocyte and stem cell composition of the allograft.
    Noga SJ; Davis J; Schepers K; Eby L; Berenson RJ
    Prog Clin Biol Res; 1994; 389():317-24. PubMed ID: 7535437
    [No Abstract]   [Full Text] [Related]  

  • 2. T-cell depletion from allogeneic bone marrow by counterflow centrifugation is not associated with a substantial loss of CD34-positive cells.
    Preijers F; Ruijs P; Schattenberg A; de Witte T
    Prog Clin Biol Res; 1994; 389():339-44. PubMed ID: 7535440
    [No Abstract]   [Full Text] [Related]  

  • 3. Selection of BCR/ABL-negative progenitor cells from chronic myeloid leukemia marrow.
    Leemhuis T; Leibowitz D; Cox G; Srour EF; Tricot G; Hoffman R
    Prog Clin Biol Res; 1992; 377():231-7. PubMed ID: 1279706
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.
    Champlin R; Giralt S; Przepiorka D; Ho W; Lee K; Gajewski J; Nimer S; Andersson B; Wallerstein R; Ippolito C
    Prog Clin Biol Res; 1992; 377():385-94; discussion 395-8. PubMed ID: 1438435
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of the degree of maturation and differentiation of CD34+ cells in grafts of different origin on the duration of aplasia.
    Wunder E; Sovalat H; Liang H; Becker M; Henon P
    Prog Clin Biol Res; 1994; 389():345-50. PubMed ID: 7535441
    [No Abstract]   [Full Text] [Related]  

  • 6. The AIS CELLector: a new technology for stem cell purification.
    Okarma T; Lebkowski J; Schain L; Harvey M; Tricot G; Srour E; Meyers WG; Burnett A; Sniecinski I; O'Reilly RJ
    Prog Clin Biol Res; 1992; 377():487-502; discussion 503-4. PubMed ID: 1279717
    [No Abstract]   [Full Text] [Related]  

  • 7. CD34+ and CD33+ stem cells: predictors of hematologic recovery?
    Ross RE; Jeter EK; Stuart RK; Self SE; Lavia MF
    Prog Clin Biol Res; 1992; 377():505-12. PubMed ID: 1279718
    [No Abstract]   [Full Text] [Related]  

  • 8. Graft versus host tolerance in dogs across one DLA-haplotype by depletion of CD6 positive cells.
    Schumm M; Kolb HJ; Hahn J; Beisser K; Rieber P; Günther W; Büttner M; Wilmanns W; Thierfelder S
    Prog Clin Biol Res; 1992; 377():419-25. PubMed ID: 1438440
    [No Abstract]   [Full Text] [Related]  

  • 9. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
    Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
    Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34+ selected cells in clinical transplantation.
    Collins RH
    Stem Cells; 1994 Nov; 12(6):577-85. PubMed ID: 7533577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomagnetic CD8 depletion.
    Jansen J; Hanks S; Akard L; Martin M; Ash R; Thompson J; English D
    Prog Clin Biol Res; 1994; 389():551-6. PubMed ID: 7700920
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
    Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
    Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.
    Przepiorka D; Huh YO; Khouri I; Reading C; Hester J; Marshall M; Champlin RE
    Prog Clin Biol Res; 1994; 389():557-63. PubMed ID: 7700921
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of a closed system for V alpha beta-positive T cell depletion of marrow for use in partially mismatched related donor (PMRD) transplantation.
    Lee C; Brouillette M; Lamb L; Pati A; Brown S; Thompson J; Parrish R; Henslee-Downey PJ; Gee AP
    Prog Clin Biol Res; 1994; 389():523-32. PubMed ID: 7700917
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts.
    Vervoordeldonk SF; Merle PA; Steenbergen EJ; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC
    Prog Clin Biol Res; 1994; 389():601-9. PubMed ID: 7700926
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and positive selection of human progenitor/stem cells for bone marrow transplantation.
    Civin CI
    Prog Clin Biol Res; 1992; 377():461-72; discussion 473. PubMed ID: 1279715
    [No Abstract]   [Full Text] [Related]  

  • 17. Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.
    Schriber JR; Dejbakhsh-Jones S; Kusnierz-Glaz CR; Ginzton N; Still B; Negrin RS; Greenberg P; Strober S
    Exp Hematol; 1995 Aug; 23(9):1024-9. PubMed ID: 7543414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-phase approach to B lymphocyte purging of autologous bone marrow grafts for patients with malignant lymphoma contaminated bone marrow.
    Farley TJ; Preti RA; Ahmed T; Ciavarella D
    Prog Clin Biol Res; 1994; 389():105-9. PubMed ID: 7535430
    [No Abstract]   [Full Text] [Related]  

  • 19. The combined use of elutriation and CD8/magnetic bead separation to engineer the bone marrow allograft.
    Noga SJ; Davis JM; Vogelsang GB; Donnenberg AD; Thoburn C; Schepers K; Sproul J
    Prog Clin Biol Res; 1992; 377():411-8. PubMed ID: 1438439
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow purging with antisense oligodeoxynucleotides.
    Gewirtz AM
    Prog Clin Biol Res; 1992; 377():215-24; discussion 225-6. PubMed ID: 1438418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.